Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04588233 · ClinicalTrials.gov registry record · NA
Melatonin Adolescent Research Study
A NA study of Sleep Disorders in Children, sponsored by Loma Linda University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT04588233 is a NA study of Sleep Disorders in Children that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 80 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT04588233, a NA study of Sleep Disorders in Children, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
The present study will use a within-person, randomized cross-over experimental design to test the effects of exogenous melatonin supplementation on the sleep and daytime functioning of typically developing adolescents with short or disrupted sleep of behavioral origins (i.e., difficulty falling asleep, staying asleep, or premature waking resulting in short or disrupted sleep not attributed to an organic sleep condition).
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Melatonin
Study Locations (2)
California
- Loma Linda University - Loma Linda
- Loma Linda U - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04588233
The ClinicalTrials.gov registry entry for NCT04588233 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Disorders in Children appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04588233 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04588233 about?
NCT04588233 is a clinical study titled "Melatonin Adolescent Research Study". The present study will use a within-person, randomized cross-over experimental design to test the effects of exogenous melatonin supplementation on the sleep and daytime functioning of typically developing adolescents with short or disrupted sleep of behavioral origins (i.e., difficulty falling asle...
What is the current status of trial NCT04588233?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-09-15. Estimated completion is 2026-05.
What conditions does trial NCT04588233 study?
This clinical trial studies the following conditions: Sleep Disorders in Children.
What interventions are being tested in trial NCT04588233?
The interventions under investigation include: Placebo (OTHER), Melatonin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04588233?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04588233 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.